“Trastuzumab in the Second-Line Treatment of HER2-Positive Metastatic Gastric Cancer. Experience of the Moscow Oncology Service”. Voprosy onkologii 72, no. 2 (May 8, 2026): OF-2514. Accessed October 14, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/2-26-Trastuzumab.